Dr. Willemsen
ActiveDr. Willemsen has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €264k and a net result of €88k. Equity is growing by ~66.1% per year across the filed fiscal years. Its solvency ranks better than 95% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
short-term debt: 0.9% and cash: 73.7% of total assets, and 0.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
99.1%
Return on assets
32.9%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-05-2025, 64 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
not confirmed
2024
64 d early
2023
70 d early
2022
123 d early
2021
19 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€264k▲ 49.8%
2023 · €176k
2021: €60k
2022: €93k
2023: €176k
2021 → 2024
Total assets
€266k▲ 46.1%
2023 · €182k
2021: €64k
2022: €98k
2023: €182k
2021 → 2024
Net result
€88k▲ 5.3%
2023 · €83k
2021: €55k
2022: €33k
2023: €83k
2021 → 2024
Working capital
€263k▲ 49.2%
2023 · €176k
2021: €60k
2022: €93k
2023: €176k
2021 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2021202220232024Trend
Equity€60k-€93k▲ 54.8%€176k▲ 89.5%€264k▲ 49.8%
Operating result€70k-€43k▼ 39.2%€106k▲ 148%€112k▲ 5.3%
Net result€55k-€33k▼ 40.2%€83k▲ 153%€88k▲ 5.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 5% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €266k
Fixed assets
€955
Current assets
€266k
Equity and liabilities €266k
Equity
€264k▲ 49.8%
Debt
€2k▼ 59.5%
The debt ratio falls from 3.3% to 0.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€112k
Cash flow
€88k
Solvency
99.1%▲
2023 · 96.7%
Debt / equity
0.01▼
2023 · 0.03
ROE
33.2%▼
2023 · 47.2%
ROA
32.9%▼
2023 · 45.7%
Interest coverage
184.78
Debt
€2k▼
2023 · €6k
Debt ≤ 1 year
€2k▼
2023 · €6k
Income taxes
€24k▲
2023 · €23k
A ratio outside any meaningful range has been withheld (balance sheet total €266k, equity €264k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€182k€266k▲
Fixed assets21/28-€955
Tangible fixed assets22/27-€955
Plant, machinery and equipment23-€955
Current assets29/58€182k€266k▲
Amounts receivable within one year40/41€933€1k▲
Other amounts receivable41€933€1k▲
Current investments50/53€61k€67k▲
Cash at bank and in hand54/58€120k€196k▲
Deferred charges and accrued income490/1€296€470▲
Equity and liabilities
Total equity and liabilities10/49€182k€266k▲
Equity10/15€176k€264k▲
Contributions10/11€5k€5k=
Reserves13€171k€259k▲
Distributable reserves133€171k€259k▲
Profit (loss) carried forward14€313€30▼
Amounts payable17/49€6k€2k▼
Amounts payable within one year42/48€6k€2k▼
Trade debts44€2k€2k▲
Suppliers440/4€2k€2k▲
Taxes, remuneration and social security45€5k-
Taxes450/3€5k-
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€383
Other operating charges640/8€768€787▲
Gross operating margin9900€107k€113k▲
Operating profit (loss)9901€106k€112k▲
Financial income75/76B€248€538▲
Recurring financial income75€248€538▲
Financial charges65/66B€701€608▼
Recurring financial charges65€701€608▼
Profit (loss) for the period before taxes9903€106k€112k▲
Income taxes67/77€23k€24k▲
Profit (loss) for the period9904€83k€88k▲
Profit (loss) for the period to be appropriated9905€83k€88k▲
Appropriation of the result
Profit (loss) to be appropriated9906€83k€88k▲
Profit (loss) brought forward from the previous period14P€40€313▲
Transfer to equity691/2€83k€88k▲
To other reserves6921€83k€88k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
28-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2021net €88k ▲5.3%
Operating result €112k, net result €88k, both a record.
31-12
Financial
Liquidity quadruplescurrent ratio 108.33
Current ratio from 30.14 to 108.33; short-term debt falls from €6k to €2k.
31-12
Financial
Equity above €200kEq €264k ▲49.8%
4 profitable years in a row build equity to €264k.
22-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €150kEq €176k ▲89.5%
3 profitable years in a row build equity to €176k.
30-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €33k ▼40.2%
Net result drops to €33k, the lowest in the series; recovery starts the following year.
12-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kalmthout · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Maatjesstraat (Nm) 42920 KalmthoutGround area
781 m²
Building footprint
155 m²
Volume, LiDAR
67 m³
Parcel 11662C0443/00P002, Flanders · tallest building 2.9 m. Linked by address, not a title deed.
1 establishment unit
Dr. Willemsen
since 20202.310.333.825
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11662C0443/00P002 | Flanders | 781 m² | 1 · 155 m² | 2.9 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
NEUROGEN
BE 0474.427.988
Jette · Eq €264k
ORTHOMEDEX
BE 0836.215.323
Oostende · Eq €264k
AREX MEDICAL
BE 0737.645.210
Zaventem · Eq €264k
Dr. Gert Van Ooteghem
BE 0798.443.028
Gent · Eq €264k
Huisartsenpraktijk Vermaercke Cassandra
BE 0836.535.324
Oosterzele · Eq €264k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,284 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded08-12-2020
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.